Biomea Fusion, Inc.
BMEA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.09 | -0.18 | -0.05 | -0.02 |
| FCF Yield | -85.84% | -20.18% | -25.71% | -21.72% |
| EV / EBITDA | -0.64 | -2.64 | -1.65 | -0.84 |
| Quality | ||||
| ROIC | -238.75% | -70.26% | -75.47% | -22.94% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.87 | 0.82 | 0.76 | 0.85 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -20.30% | -57.55% | -64.33% | -756.08% |
| Safety | ||||
| Net Debt / EBITDA | 0.35 | 1.34 | 1.32 | 3.45 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |